OALVX
Price
$19.89
Change
+$0.14 (+0.71%)
Updated
Jul 3 closing price
Net Assets
1.91B
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

OALVX vs VIVIX

Header iconOALVX vs VIVIX Comparison
Open Charts OALVX vs VIVIXBanner chart's image
Optimum Large Cap Value A
Price$19.89
Change+$0.14 (+0.71%)
VolumeN/A
Net Assets1.91B
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
OALVX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OALVX vs. VIVIX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OALVX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. OALVX (1.91B). VIVIX pays higher dividends than OALVX: VIVIX (2.19) vs OALVX (0.78). OALVX was incepted earlier than VIVIX: OALVX (22 years) vs VIVIX (27 years). OALVX (1.21) is less costly to investors than VIVIX (0.04). OALVX is a more actively managed with annual turnover of: 11.00 vs. VIVIX (9.00). OALVX has a lower initial minimum investment than VIVIX: OALVX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 11.41 vs. OALVX (6.58). VIVIX return over 5 years is better than : 79.11 vs. OALVX (37.86).
OALVXVIVIXOALVX / VIVIX
Total Expense Ratio1.160.042,900%
Annual Report Gross Expense Ratio1.210.043,025%
Fund Existence22 years27 years-
Gain YTD7.1045.609127%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.91B189B1%
Annual Yield % from dividends0.782.1936%
Returns for 1 year6.5811.4158%
Returns for 3 years10.4534.4030%
Returns for 5 years37.8679.1148%
Returns for 10 years35.96114.4531%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
BNL16.340.14
+0.86%
Broadstone Net Lease
EYPT9.720.06
+0.62%
EyePoint Pharmaceuticals
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc